Delivery Order SPE2DB20D9354-SPE2DB25FX7Z3
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, valued at $5,207.70 with an ultimate completion date of August 21, 2025, was issued without a set-aside designation. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. The contract, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, is structured as a firm fixed-price delivery order without a set-aside designation. This award represents a direct delivery under DMS Pharmaceutical Group's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $26,038.50 by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, which is scheduled for completion by September 22, 2025, was issued without a set-aside designation, allowing the contractor to compete on an unrestricted basis. The award represents a specific...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at approximately $12.5K by the Defense Logistics Agency (DLA) on July 25, 2025, for Mirena 52 mg systems with an ultimate completion date of August 15, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,041.56 by the Defense Logistics Agency (DLA) on August 26, 2025, for Mirena 52 mg systems. The award is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $10,415.40 by the Defense Logistics Agency on September 5, 2025, for the supply of Mirena 52 mg systems. The contract, which carries no set-aside designation, is scheduled for ultimate completion by September 26, 2025, with performance occurring at the vendor's Park Ridge facility. This delivery order represents a discrete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,124.68 by the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Mirena 52 mg contraceptive systems. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 7, 2025, and carries no set-aside designation. This award represents a single transaction under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency for 52 mg Mirena systems valued at $1,562.31. The award, issued on September 16, 2025, with an ultimate completion date of October 7, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Mirena 52 mg systems, with a ceiling value of $1,041.56. The award, issued on August 6, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 27, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D9354Indefinite Delivery Contract
- SPE2DB20D9354-SPE2DB25FX7Z3Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 19, 2025, valued at $1,562.31 for Mirena 52 mg systems by the Defense Logistics Agency (DLA). This firm fixed-price delivery order, with an ultimate completion date of October 10, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly based on its established capability as a federal pharmaceutical supplier. The Mirena system, a contraceptive implant device, will be delivered to the Park Ridge, Illinois location for distribution through the DLA's supply chain supporting military healthcare facilities. This delivery order exemplifies DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply chain. The company maintains a $500 million single-award IDC with the DLA under the SPE2DB program, valid through November 2026, which enables the issuance of firm fixed-price delivery orders for an extensive portfolio of pharmaceutical products supporting Department of Defense healthcare systems worldwide. DMS Pharmaceutical Group's contract award history demonstrates consistent success in securing pharmaceutical deliveries across diverse product categories, from specialty medications to medical devices, positioning the firm as a dependable vendor for military health facility supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/19/25 |